Murray Wan
Principal Scientist, Mariana Oncology
Peptide Radiopharmaceutical Panel
Abstract
Mariana Oncology is designing, developing, and manufacturing a new generation of precision radioligand therapies that represent a revolutionary approach to cancer treatment.
Bio
Murray Wan is a Principal Scientist in the Medicinal Chemistry group at Mariana Oncology. He earned his Master's degree in Organic Chemistry from Baylor University in 2017, following undergraduate studies in Organic Chemistry at the University of Rochester. After completing his studies, he joined Merck's Discovery Chemistry group in Boston. Initially focused on small molecule drug discovery, he later transitioned to peptide chemistry. Now at Mariana Oncology, Murray contributes to discovery chemistry efforts on various Radio Ligand Therapy (RLT) programs.